Return to Contents in this Issue |
Practitioner's Corner |
Omalizumab (an Anti-IgE Antibody) in the Treatment of Severe Atopic Eczema |
ME Ramírez Del Pozo, E Contreras Contreras, J López Tiro, J Gómez Vera |
Allergy and Clinical Immunology Service, Regional Hospital Licenciado Adolfo López Mateos, ISSSTE, Mexico City, Mexico |
J Investig Allergol Clin Immunol 2011; Vol. 21(5): 410-421 |
|